Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.88 |
| ▸ | NPC1 | O15118 | 4/20 | 0.88 |
| ▸ | CDK5 | Q00535 | 7/20 | 0.79 |
| ▸ | CDK5R1 | Q15078 | 7/20 | 0.79 |
| ▸ | MAPT | P10636 | 5/20 | 0.79 |
| ▸ | LMNA | P02545 | 1/20 | 0.79 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.74 |
| ▸ | CDK2 | P24941 | 5/20 | 0.74 |
| ▸ | TUBB8B | A6NNZ2 | 1/20 | 0.74 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.74 |
| ▸ | TUBB | P07437 | 1/20 | 0.74 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.74 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.74 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.74 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.74 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.74 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.74 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.74 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4395515 | 1.00 | MEN1 (0.88) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL4397229 | 0.94 | MEN1 (1.00) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL4398263 | 0.92 | CDK5 (0.72) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL20142433 | 0.91 | MEN1 (0.72) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL20142350 | 0.89 | MEN1 (0.91) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL5726218 | 0.89 | MEN1 (0.91) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL4402578 | 0.89 | MEN1 (0.91) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL4489624 | 0.89 | MEN1 (0.91) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL20142856 | 0.88 | MEN1 (1.00) | MEN1KMT2ANPC1CDK5CDK5R1 | |
| SCHEMBL20142446 | 0.88 | MEN1 (0.88) | MEN1KMT2ANPC1CDK5CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139286-B1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AG (DE) | 2025-02-26 | — | — | EP | disclosed |
| US-11964953-B2 | Substituted aminothiazoles as DGKzeta inhibitors for immune activation | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-23 | — | — | US | disclosed |
| US-20230167078-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230167078-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230139936-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-04 | — | — | US | disclosed |
| US-20230139936-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-04 | — | — | US | disclosed |
| US-8829014-B2 | Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2014-09-09 | — | — | US | disclosed |
| EP-2007393-B1 | THIAZOLE AND THIOPHENE ANALOGUES, AND THEIR USE IN TREATING AUTOIMMUNE DISEASES AND CANCERS | UNIV LOUISIANA STATE (US) | 2013-08-21 | — | — | EP | disclosed |
| US-20120283268-A1 | Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers | GIORDANO ANTHONY (US) | 2012-11-08 | — | — | US | disclosed |
| US-8217037-B2 | Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2012-07-10 | — | — | US | disclosed |
| US-20090306073-A1 | Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers | B.V. PATEL PHARMACEUTICAL EDUCATION & RESEARCH DEVELOPMENT (PERD) CENTRE (IN) | 2009-12-10 | — | — | US | disclosed |
| EP-2007393-A2 | THIAZOLE AND THIOPHENE ANALOGUES, AND THEIR USE IN TREATING AUTOIMMUNE DISEASES AND CANCERS | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College (US) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007118149-A2 | THIAZOLE AND THIOPHENE ANALOGUES, AND THEIR USE IN TREATING AUTOIMMUNE DISEASES AND CANCERS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL LOLLEGE (US) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139936-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | DGKZ, DGKA, DGKG | MEN1 4344/4885KMT2A 1150/4885NPC1 3336/4885 |
| US-20090306073-A1 | Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers | TPMT, TST, SSB | MEN1 1180/4885KMT2A 2707/4885NPC1 3673/4885 |
| US-20230167078-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | DGKZ, DGKA, DGKG | MEN1 4344/4885KMT2A 1150/4885NPC1 3336/4885 |
| US-20120283268-A1 | Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers | TPMT, TST, SSB | MEN1 1180/4885KMT2A 2707/4885NPC1 3673/4885 |
| US-11964953-B2 | Substituted aminothiazoles as DGKzeta inhibitors for immune activation | DGKZ, DGKA, DGKG | MEN1 4344/4885KMT2A 1150/4885NPC1 3336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.